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Abstract
Pulmonary surfactant is a mixture of lipids and proteins which is secreted by the epithelial type II cells into the alveolar
space. Its main function is to reduce the surface tension at the air/liquid interface in the lung. This is achieved by forming a
surface film that consists of a monolayer which is highly enriched in dipalmitoylphosphatidylcholine and bilayer lipid/protein
structures closely attached to it. The molecular mechanisms of film formation and of film adaptation to surface changes
during breathing in order to remain a low surface tension at the interface, are unknown. The results of several model systems
give indications for the role of the surfactant proteins and lipids in these processes. In this review, we describe and compare
the model systems that are used for this purpose and the progress that has been made. Despite some conflicting results using
different techniques, we conclude that surfactant protein B (SP-B) plays the major role in adsorption of new material into the
interface during inspiration. SP-C’s main functions are to exclude non-DPPC lipids from the interface during expiration and
to attach the bilayer structures to the lipid monolayer. Surfactant protein A (SP-A) appears to promote most of SP-B’s
functions. We describe a model proposing that SP-A and SP-B create DPPC enriched domains which can readily be adsorbed
to create a DPPC-rich monolayer at the interface. Further enrichment in DPPC is achieved by selective desorption of non-
DPPC lipids during repetitive breathing cycles. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Pulmonary surfactant is a mixture of lipids and
proteins which is secreted into the alveolar space
by epithelial type II cells. The main function of sur-
factant is to lower the surface tension at the air/liq-
uid interface within the alveoli of the lung. This is
needed to lower the work of breathing and to pre-
vent alveolar collapse at end-expiration. The surface
tension of the air/liquid interface within the lung
reaches values close to 1 mN/m at low lung volumes
[1]. A lipid monolayer enriched in dipalmitoylphos-
phatidylcholine (DPPC) then covers the interface and
is responsible for this low surface tension. Bilayer
lipid structures are attached to the lipid monolayer
and together they make up the surface ¢lm, as was
visualized by electron microscopy [2,3]. These bilayer
structures are thought to be in direct contact with the
monolayer and to form the lipid reservoir from
which insertion of lipids and possibly proteins is
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achieved upon inhalation. One study showed tubular
myelin, a surfactant speci¢c lattice-like lipid struc-
ture, being in continuum with the monolayer, indi-
cating that the lipids of tubular myelin very likely
feed the monolayer and can be part of the surface
¢lm [4].
The role of the di¡erent components of surfactant
in the surface ¢lm structure and formation is becom-
ing more evident. This is largely due to new model
systems with reconstituted puri¢ed surfactant com-
ponents. However, much remains to be learned re-
garding the molecular mechanisms and actions of
especially the surfactant proteins. We review the cur-
rent knowledge on the formation and dynamics of
the surfactant ¢lm, focusing on the role that model
systems played in assigning separate functions to the
individual surfactant components.
2. Composition of pulmonary surfactant
Surfactant is composed of approximately 90% lip-
ids and 10% proteins. The four surfactant speci¢c
proteins are designated surfactant protein A (SP-
A), SP-B, SP-C and SP-D. These proteins can be
divided into two groups, SP-B and SP-C are two
small hydrophobic proteins, while SP-A and SP-D
are large hydrophilic proteins. In the subsequent sec-
tions, the structure, composition and some general
functions of the surfactant components are de-
scribed. Since SP-D does not appear to possess any
activity related to reducing the surface tension, this
protein will not be further discussed in the current
review. For more information on this protein the
reader is referred to other review articles [5^7].
2.1. Lipids
The main constituents of surfactant are lipids. The
composition of the surfactant lipid pool is quite dif-
ferent from that of other membrane systems. In all
mammalian species, surfactant contains high
amounts (approximately 80%) of phosphatidylcho-
line (PC) [8,9]. Generally, it is assumed that approx-
imately 60% of the PC is in the dipalmitoylated form,
but lower amounts of DPPC have been found as well
[10,11]. A recent report by Brouwers et al. [12], using
a new sensitive HPLC method to determine PC spe-
cies, describes a lower value of DPPC of approxi-
mately 40% in porcine surfactant. Other constituents
are 16:0, 18:2 PC (18%) 16:0, 18:1 PC (20%) and
16:0, 16:1 PC (13%). Phosphatidylglycerol (PG)
comprises approximately 10% of the lipid pool and
small amounts of (lyso) phosphatidic acid (PA),
phosphatidylinositol (PI) and phosphatidylethanol-
amine (PE) are found. Cholesterol is the most abun-
dant neutral lipid present in pulmonary surfactant.
DPPC is generally accepted as being the lipid re-
sponsible for generating a near-zero surface tension
at the interface during compression [13]. The two
saturated acyl chains enable the lipid to form a
tightly packed monolayer which can generate these
low surface tension values without collapsing. The
unsaturated PC lipids might be important in the for-
mation of a lipid reservoir, in the initial adsorption
of lipids to the interface or in the regulation of sur-
face tension during the respiratory cycle. Other func-
tions in intracellular events, such as lamellar body
assembly, transport or secretion, are also possible.
However, no speci¢c role for any of the unsaturated
PC species has so far been proven.
The unusually high amount of PG in surfactant
indicates a particular role for this acidic phospholip-
id. DPPC:PG mixtures have increased adsorption
activity compared to PC mixtures, also when the
hydrophobic proteins SP-B and SP-C are present.
A direct interaction of the negatively charged PG
with the positive charges of SP-B and SP-C seems
likely to be involved and indications for interaction
with SP-B have been observed [14^16]. The levels of
PI, which is also negatively charged, are usually low,
although some exceptions exist. Surfactants from
adult rhesus monkey [17] and guinea-pig [18] have
relatively high amounts of PI and lower amounts
of PG compared to most other species. PG can be
replaced by PI in SP-B mediated lipid mixing or ad-
sorption experiments without any loss of activity
[19,20]. Rabbits that were fed a high inositol diet
creating a high PI/PG ratio in their surfactant
showed no signs of surfactant or lung dysfunction
[21] although another group observed di¡erences in
the lamellar body turnover rate in similarly fed rats
[22]. It will be interesting to see whether speci¢cally
PG is required for a role in surfactant and/or surface
¢lm homeostasis or if any acidic lipid can substitute
for PG.
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The role of cholesterol and minor lipid compo-
nents like lysoPC, PE or PA in surfactant is far
from clear. Cholesterol likely increases the £uidity
of the DPPC-rich surfactant membrane systems,
and the minor lipid components might induce struc-
tures of curvature in, for example, tubular myelin.
The in£uence of both the minor lipid components
and cholesterol on surfactant function has not been
extensively studied and it is obvious that more work
has to be performed to achieve a better understand-
ing of their roles.
2.2. Surfactant protein A
Surfactant protein A was the ¢rst surfactant-spe-
ci¢c protein to be detected. Its monomeric form has
a molecular mass of 26 kDa on SDS^PAGE with
several bands observed at higher molecular masses
[23]. These represent glycosylated forms due to sialic
acid containing complex carbohydrates attached to
asparagine [24]. The primary amino acid sequence
of SP-A shows that the protein can be divided into
four structural domains: (1) a short N-terminal seg-
ment; (2) a proline-rich collagen-like domain; (3) a
neck region; and (4) a carbohydrate recognition do-
main. The active form of SP-A is an octadecamer
built up from six trimers which forms an open £ower
bouquet [25] (Fig. 1). The formation of collagen-like
triple helices results in a trimer structure followed by
disul¢de linkage of six of these trimers by the
N-terminal segments.
The concepts concerning the function of SP-A
have changed dramatically over the past few years.
Initial in vitro experiments indicated that this protein
is involved in surfactant function and homeostasis,
including: (1) tubular myelin formation [26^28]; (2)
protection of the surface ¢lm against protein inhibi-
tion [29^31]; (3) enhancement of SP-B’s surface ac-
tivity [32,33]; and (4) regulation of uptake and secre-
tion of surfactant by type II cells [34^36]. In recent
years, the emphasis of SP-A research has shifted to-
wards its role in host defense [37^39]. SP-A-de¢cient
mice, produced by targeting the SP-A locus by ho-
mologous recombination in embryonic stem cells
[28,40], gave more insight into the in vivo function
of the protein. These animals lack tubular myelin
and are more susceptible to several pathogens, con-
¢rming the host defense role. On the other hand, the
animals unexpectedly have normal oxygenation, ap-
parently contradicting the role of the protein in sur-
face ¢lm formation. However, the surfactant dys-
functions due to the lack of SP-A might be more
subtle and only show up in stress situations. Further
characterization of these mice will de¢nitely provide
a better understanding of the complexity of the SP-A
functions and their relative importance.
Because of the distinct structural segments of
SP-A, several functions of the protein can be as-
signed to di¡erent segments. Much information re-
garding this structure^function relationship has been
produced by synthesizing mutant forms of the pro-
tein in the baculovirus expression system with the
mutations varying from point mutations up to dele-
tions of whole segments. To describe a detailed over-
view of these studies is beyond the scope of this re-
view and the reader is referred to other articles (for a
review see [41]).
2.3. Surfactant protein B
Surfactant protein B is a hydrophobic protein that
consists of 79 amino acids and forms a homodimer
of V17 kDa [32]. Due to its hydrophobicity, SP-B
will interact with lipids. This has been observed using
several techniques including electron spin resonance
[14] and £uorescence anisotropy [16]. SP-B has a net
positive charge and the positive charges of SP-B are
thought to interact with anionic lipids [16,42]. An-
other characteristic feature of SP-B is that it contains
three intramolecular disul¢de bridges and one inter-
molecular disul¢de bridge which results in the dimer
form of the protein [43]. The mature protein is
formed from a preprotein of 42 kDa after cleavage
of both N-terminal as well as C-terminal sequences
[44,45]. The proprotein can be arranged in three tan-
dem repeats, based on the primary sequence and es-
pecially the conserved cysteine periodicity. This motif
is also observed in the family of ‘saposin-like pro-
teins’ [46,47]. The structure of one family member,
NK-lysin, has been determined recently by NMR
and shows that the protein contains ¢ve helices
that interact with the membrane surface [48]. It is
tempting to predict a similar structure for SP-B,
but other models with varying lengths and number
of K-helices within the protein have been proposed.
One of them is shown in Fig. 1. One major di¡erence
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between SP-B and the other family members of the
saposin-like family is the homodimer formation of
SP-B.
Fourier transform infrared experiments have
shown that 27^45% of the secondary structure of
SP-B is helical, independent of the presence of lipids
or calcium [49,50]. The axes of the helices lie nearly
parallel to the interface of a lipid bilayer [51], which
is in agreement with the proposed amphipathic char-
acter of the helices. It was observed that addition of
SP-B to preformed lipid vesicles led to the formation
of small bilayer disks [52,53]. The authors proposed
that SP-B lined the edges of these discs protecting the
phospholipid acyl chains from interaction with
water. The discs fused rapidly into membranous bi-
layer sheets that assembled into multilayer stacks,
which could be important for lamellar body forma-
tion inside the type II cell. Recent reports show that
the exact interaction of SP-B with the membrane
depends on the method of reconstitution [54,55].
SP-B reconstituted from lipid/protein mixtures pene-
trates deeper into the lipid bilayer than SP-B added
to preformed liposomes and this in£uences its activ-
ity in Wilhelmy balance studies. This problem will
make it more di⁄cult to determine the exact struc-
ture of the protein in a lipid environment.
The importance of SP-B in surfactant is apparent
from the lethal respiratory distress that is caused by
SP-B de¢ciency in humans [56] and in SP-B knock-
out mice [57]. SP-B has been shown to have many
activities in in vivo and in vitro assays. These include
promotion of lipid adsorption to the air/liquid inter-
face [58], formation of tubular myelin [26,27], re-
spreading of ¢lms from collapse phase [59], reuptake
of surfactant by type II cells [60,61], stabilization of
monolayer lipid ¢lms, membrane binding, membrane
fusion and lysis [53]. Some of these functions will be
discussed in more detail later in this review. The
homodimer formation of SP-B is thought to be im-
portant for several of these functions. Each mono-
mer can interact with a membrane system and in that
way SP-B could bring two membranes in close prox-
imity (Fig. 1). The connection to the fusogenic and
aggregating properties of SP-B is easily pictured.
However, no proof for this localization of the protein
has been found and further studies using monomeric
SP-B must still be performed [62].
A more surprising role of SP-B might be found in
host defense. Recently, it was described that a syn-
thetic SP-B peptide inhibits bacterial growth [63].
The fusogenic properties measured in vitro might
be important for this function. The sequence homol-
ogy of SP-B with other antibacterial peptides like the
saposins and dermaseptins is consistent with this
function. Finally, one study describes the detection
of SP-B in the gastrointestinal tract (as well as SP-A
and SP-D) [64] which also argues for a more ex-
tended function of SP-B than just surface activity
related ones.
Fig. 1. Structure of the surfactant proteins A, B and C.
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2.4. Surfactant protein C
Surfactant protein C is the only true surfactant
protein in the sense that it is the one protein that
seems to be present only in pulmonary surfactant
[65]. The only site of synthesis discovered so far is
the alveolar type II cell. SP-C is a 35 amino acid
peptide which is formed from a 21-kDa proprotein
after cleavage of the N- and C-terminal precursor
parts. Its main characteristic is its extreme hydropho-
bicity. Other conserved characteristics are two posi-
tive charges at positions 11 and 12 (lysine and argi-
nine) and two palmitoylated cysteines in the N-
terminal part, £anked by 2 proline residues [66]. A
reported exception is canine SP-C which has only
one palmitoylated cysteine [58]. The structure of
the protein in an apolar solvent has recently been
resolved by NMR and features a valyl-rich K-helix
formed by amino acids 9^34 [67] (Fig. 1). This struc-
ture correlates well with secondary structure analysis
by circular dichroism and Fourier transform infra-
red. Using the latter technique, it was observed
that the K-helical content increases even more in a
lipid environment [68,69] and might extend to the
two palmitoyl chains at position 5 and 6 in the pep-
tide chain. The N-terminus has a less de¢ned struc-
ture, but might form a L-sheet in a lipid environ-
ment.
The membrane spanning K-helix of SP-C contains
16 consecutive branched residues (Val, Ile and Leu)
and is known to be a very stable and rigid structure.
Recent studies describe that the K-helix is in a meta-
stable phase when the protein is in solution and SP-C
slowly transforms through several intermediates into
thermodynamically favorable aggregates of SP-C
with a mainly L-sheet conformation [70]. However,
when SP-C was embedded in micelles this transfor-
mation was not observed. In addition, algorithms
designed for the identi¢cation of transmembrane re-
gions predict an K-helix for residues 13^33 of SP-C in
a lipid environment, while a L-sheet conformation is
predicted in aqueous solutions. Due to the meta-
stability of the protein in solution, production of
correctly folded synthetic SP-C has been problematic
[71], although one study describes a very mild pro-
duction method resulting in SP-C with a high K-helix
content [72]. We have recently shown that produc-
tion of recombinant mature SP-C in the baculovirus
expression system yields correctly folded protein [73],
probably due to the lipid environment present while
SP-C is produced. This also indicates that the pre-
cursor parts of SP-C are not required for this pro-
cess.
The two acyl chains of SP-C constitute an intrigu-
ing part of this protein. In general, acylation of pro-
teins might serve several purposes. For example, pal-
mitoylation of cytosolic proteins might allow their
attachment to membranes which is observed with
many G-proteins [74,75]. Palmitoylation of integral
membrane proteins is also observed and is often
linked to receptor activation or translocation [76].
It is noteworthy that palmitoylation of these proteins
often occurs at cysteines close to the membrane span-
ning helix, in the proximity of basic residues. This
resembles the situation found in SP-C and may in-
dicate a general palmitoylation motif. This is sup-
ported by our recent work which shows that mature
SP-C produced in insect cells is palmitoylated as well
[73]. Although only 15% of the total amount was in
the dipalmitoylated form, it does imply that the ma-
ture sequence is su⁄cient for palmitoylation. In the
case of SP-C, dynamic palmitoylation/depalmitoyla-
tion has not been observed and the palmitoyl groups
seem to be a constant part of the protein. This would
rule out that, at least in the extracellular lining £uid,
palmitoylation of SP-C has a regulatory function.
However, there have been several plausible roles de-
scribed for the palmitoylation of SP-C, such as an
e¡ect on lamellar body assembly [77], SP-C’s surface
activity [71,78,79] and the orientation of the protein
in bi- and monolayers [69,79].
In contrast to SP-B, there have only been a few
activities described for SP-C, which largely overlap
SP-B’s activities. These are promotion of lipid ad-
sorption into an air/liquid interface [80], respreading
of ¢lms from the collapse phase [59], reuptake of
surfactant by type II cells [60,61], and stabilization
of the monolayer lipid ¢lm [78]. All these functions
are extracellular and, except for surfactant re-uptake,
contribute to ¢lm homeostasis. Whether SP-C also
has intracellular functions in, for example, lamellar
bodies is not clear.
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3. Model systems
3.1. Methodology
The progress in understanding the function of sur-
factant proteins has paralleled the invention of new
experimental techniques. Especially with regard to
the hydrophobic proteins, for which a simple func-
tionality assay is still lacking, these new techniques
are of great value for assigning the various interac-
tions involved in the complex life cycle of the surface
¢lm to distinct domains of the proteins. The general
picture one obtains from the earlier experiments is
that ‘‘SP-B is capable of doing everything SP-C
does, but better’’. However, this picture is fading
with increasing sensitivity of the techniques and the
cooperation of the surfactant proteins and lipids be-
comes increasingly clear. In this section the main
model systems involved in determining the role of
surfactant proteins and to a lower extent the surfac-
tant lipids in surface ¢lm homeostasis will be de-
scribed. A general overview of the model systems is
given in Table 1.
3.1.1. Langmuir^Wilhelmy balance
One of the ¢rst model systems used to examine
surface activity of several surfactant components
was the Langmuir^Wilhelmy balance, introduced by
Clements [81]. In this method, the surface tension at
an air/water interface is directly measured by a small
plate attached to an electro balance. One of the ma-
jor advantages of this system is that a well-de¢ned
monolayer of lipids and proteins can be spread at the
air/liquid surface. Other advantages are that radiog-
raphy and epi£uorescent microscopy of the surface
¢lm can be easily performed. Especially the micros-
copy has been used quite extensively. The use of £uo-
rescently labeled proteins or lipids enables visualiza-
tion of the formation of lipid/protein domains at
varying conditions. With these experiments, a lot of
insight into the structure and the dynamics of the
surface ¢lm can be obtained. One of the major dis-
advantages of the Wilhelmy balance is that it is a
relatively static method for surface tension measure-
ments. The surface area can be varied by moving a
barrier at the surface, but this is a slow process
which does not re£ect a dynamic process like breath-
ing. Despite these limitations, important information
has been obtained and the Wilhelmy balance will
continue to be a valuable instrument to determine
surface ¢lm structure and activity of surfactant com-
ponents.
3.1.2. Pulsating bubble surfactometer
The pulsating bubble surfactometer (PBS), ¢rst de-
scribed by Enhorning in 1977 [82], consists of a small
sample chamber which is connected to the atmo-
sphere by a small capillary. An air bubble is attached
to the capillary and this bubble is pulsated by vary-
ing the pressure inside the cuvette which generates a
dynamic ‘in vitro alveolus’ system. The surface ten-
sions are calculated using the law of Young and La-
Place from the pressure gradient across the bubble.
The maximum and minimum surface tensions during
cycling are considered to be indicative of the adsorp-
tion capability of the sample and the enrichment in
DPPC of the monolayer, respectively. The advantage
of the system is that it o¡ers a fast and easy method
Table 1
General overview of the mostly used model systems to test the surface activity of surfactant components
Advantages Disadvantages Amount of material (mostly
PL) used
CBS dynamic system time-demanding procedure 0.2^0.5 Wg (spread ¢lms)
spread ¢lms possible 0.2^1 mg (adsorbed ¢lms)
PBS fast procedure leakage of material 0.05^0.5 mg
dynamic system
Wilhelmy balance spread ¢lms possible leakage of material 5^10 Wg (spread ¢lms)
lifting of surface possible no fast surface area changes
possible
0.5^5 mg (adsorbed ¢lms)
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to investigate surface activity of samples. The main
disadvantage is that the accuracy of the measurement
is decreased by leakage of material through the capil-
lary. This makes the actual surface area covered by
the ¢lm larger and precautions have to be taken
when small di¡erences between samples are assigned.
A small modi¢cation in the normally used experi-
mental procedure can prevent the capillary from
being wetted (and thereby make the area covered
by the ¢lm equal to that of the air bubble) [83].
Another disadvantage of the apparatus is that at
low surface tensions, the bubble £attens and some-
times detaches from the capillary which reduces the
accuracy of the PBS in the low surface tensions re-
gion.
Since its invention, experiments utilizing the PBS
have signi¢cantly contributed to our understanding
of surface tension reduction by pulmonary surfactant
and the role of the surfactant proteins in this process.
However, at our current stage of knowledge, the dis-
advantages of the technique make utilization of the
PBS for more detailed mechanistic studies impracti-
cal. The technique remains useful for the detection of
large di¡erences in surface tension reducing activity
among samples.
3.1.3. Captive bubble surfactometer
The captive bubble surfactometer was introduced
by Schu«rch [84] and can be seen as an improved
pulsating bubble surfactometer. An air bubble is in-
troduced into a bu¡er solution in an airtight cuvette.
The bubble £oats against an hydrophilic agar gel
that ¢lls the upper part of the cuvette. A thin layer
of bu¡er solution separates the bubble from the agar
gel, thereby preventing interaction between the agar
and the hydrophobic phospholipids and proteins at
the air/water interface of the bubble. The absence of
a tube penetrating the bubble surface prevents the
possible leakage of interface material as observed
by the PBS. The surface tension at the bubble surface
is calculated from the shape of the bubble which is
monitored by a video camera [85]. The shape
changes from a more spherical shape at high surface
tensions to more oval at low tensions. The bubble
area can be increased and decreased by changing the
pressure inside the cuvette. This is done either man-
ually by changing the volume of the subphase inside
the cuvette or by using a pressure device in the pres-
sure driven captive bubble surfactometer. This latter
technique has been described more recently by Putz
et al. [86]. The disadvantage of the pressure driven
CBS is that the pressure inside the cuvette varies
between two preset values that can produce over-
compression of the ¢lm. However, this problem can
be overcome by the introduction of a feed-back loop
that prevents further compression when minimal sur-
face tension is attained.
The CBS o¡ers several advantages over the other
methodologies described above. One of them being
that it is a dynamic fast technique which resembles
natural breathing frequencies. In addition, the CBS is
more accurate and reproducible than the pulsating
bubble surfactometer as demonstrated by a direct
comparison experiment [83]. Especially with slowly
adsorbing surfactants the CBS was recommended
to be used for accurate measurements. This is partly
due to a relatively simple di¡erence: the fact that the
subphase in a captive bubble experiment can be
stirred. Comparable to the Wilhelmy balance, spread
¢lms can be used in this technique which o¡ers the
advantage that the exact composition of the surface
¢lm is known [87]. Only nanograms of protein are
needed in this technique when spread ¢lms are used,
which also makes this a very attractive method when
small amounts of proteins are available.
A major disadvantage of captive bubble surfac-
tometry compared to PBS is that it is very time con-
suming. The calculation of the surface tensions from
the video images was until recently a very time-de-
manding process. However, software is being devel-
oped which allows the calculation of both surface
tension and area of the bubble in real time. Still,
when spread ¢lms are used, each experiment can
take several hours due to the extended experimental
protocol used for ¢lm spreading and washing plus
replenishing of the subphase. When adsorbed ¢lms
are used a few samples can be tested and analyzed
within an hour which is approaching the experimen-
tal times used in PBS experiments.
3.1.4. Scanning force microscopy
Scanning force microscopy is a relatively new tech-
nique that will undoubtedly provide more detailed
information about monolayer structure in the near
future. Even though to date only very few pulmonary
surfactant related articles have been published, the
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sensitivity and especially the new perspective in com-
parison with the older techniques is very refreshing.
Fluid and gel phase regions within the lipid mono-
layer can be determined and the activity of surfactant
samples to create a lipid bilayer reservoir can be vi-
sualized. The technique involves spreading of a
monolayer of lipids, with or without surfactant pro-
teins, at the air/water surface in a Wilhelmy balance
trough. The surface ¢lm is then transferred onto a
mica sheet and scanned with a small tip which will
experience local forces. The interaction force and,
hence, the tip to sample distance is kept constant
via feed-back and the ¢lm topology is traced. In
the case of the pulmonary surfactant, a strong adhe-
sion between the tip and the sample apparently
proved detrimental to a good imaging. The best re-
sults so far were therefore obtained in a dynamic
mode of operation of an SFM to overcome the ad-
hesion e⁄ciently [88]. The obtained pro¢le re£ects
the reservoir forming activity of surfactant samples,
but gives no information on other critical aspects of
¢lm behavior.
3.2. Data obtained from the model systems
3.2.1. Adsorption
The ¢rst adsorption experiments performed were
monolayer experiments in the Wilhelmy balance. In-
terfacial characteristics of lipids from protein con-
taining lipid vesicles in the subphase showed that
SP-B and SP-C enhanced adsorption [19,80,89] in
an additive way. The adsorption enhancing e¡ect of
SP-B and SP-C is also observed when these proteins
are only present in a spread monolayer. This e¡ect of
the surfactant proteins on adsorption was con¢rmed
in a variety of PBS and CBS experiments [78,87,90^
96]. From the above studies it is clear that both
hydrophobic proteins enhance adsorption, but the
information on the relative activity of the proteins
in the process is sometimes contradicting. For exam-
ple, SP-C has a higher activity than SP-B in a PBS
study [97] while SP-B is more active using the Wil-
helmy balance [80]. The di¡erent experimental set-
up, not only in terms of the apparatus used, but
also di¡erences related to lipid compositions, protein
concentrations, protein puri¢cation methods etc., is
the most likely cause of these di¡erences. Consider-
able discrepancy may also arise from the preparation
of the vesicles: their size determines very strongly
their stability and, hence, the ability to adsorb.
A tendency towards a higher activity, on a molar
basis, for SP-B is seen. However, taking all these
published results into account, it is unlikely that
the major functional di¡erence between SP-B and
SP-C lies in the absolute adsorption rate. Especially
with regards to the adsorption to a clear interface,
which only re£ects the ¢rst breath after birth in an in
vivo situation, it is unlikely that distinct properties
for each of the hydrophobic proteins exist. As will be
discussed below, other surface ¢lm related phenom-
ena like DPPC enrichment of the monolayer during
adsorption and reservoir formation, are more likely
dependent on the speci¢c characteristics of either SP-
B and/or SP-C.
Wilhelmy balance studies have also demonstrated
that SP-A can enhance the adsorption of SP-B con-
taining samples [32,33]. This cooperative e¡ect be-
tween SP-A and SP-B in this process was con¢rmed
in PBS studies and was shown to be calcium depen-
dent [29,98]. The minor lipid components of surfac-
tant in the vesicles have been shown to increase ad-
sorption of lipids to the monolayer as well [99^101].
This is not surprising since palmitic acid and lysoPC
are known fusogenic compounds. Also plasmalogens
have been shown to increase adsorption in CBS stud-
ies [102]. However, these e¡ects may not represent a
speci¢c role of these lipids. It can be assumed that
any compound, either proteins or lipids, that disturbs
the rigidity of the DPPC-rich bilayers used in the
vesicles, has to some extent a positive e¡ect on ad-
sorption. An interesting phenomenon is observed for
cholesterol. This neutral lipid increases the adsorp-
tion rate at lower temperature (23‡C) in PBS, and
Wilhelmy balance studies [103,104], but has an inhib-
iting e¡ect on adsorption at 37‡C. However, the in-
hibiting e¡ect at higher temperatures could not be
reproduced in captive bubble studies [105], indicating
that more studies are required to determine the role
of cholesterol.
3.2.2. Enrichment of the monolayer in DPPC
The near-zero surface tension values obtained dur-
ing static (Wilhelmy balance) or dynamic (PBS, CBS)
compression of the surface ¢lm imply that the mono-
layer has to be enriched in DPPC. Two general
mechanisms might be involved: (1) selective adsorp-
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tion of DPPC; or (2) selective removal of non-DPPC
lipids. Experimental evidence suggests that both
mechanisms occur.
(1) Evidence for selective adsorption stems mostly
from CBS studies. In the CBS, adsorbed ¢lms of
surfactant samples in suspension reached near-zero
surface tensions at much lower area reduction of
the air bubble than expected based on the lipid com-
position of the surfactant [94]. A ¢lm consisting of
pure DPPC requires 12^15% area reduction to reach
near-zero surface tension from equilibrium, and the
surfactant used in that study contained 45% DPPC.
Theoretically, if the lipid composition of the ¢lm was
the same as the bulk face, an area reduction of 55%
Fig. 2. Hypothetical in vitro model for speci¢c DPPC adsorption to the interface. SP-B is embedded in the lipids of a unilamellar
vesicle, while SP-A is present in the subphase. (1) SP-A and SP-B cooperate in the formation of DPPC enriched domains in the
vesicle bilayer. (2) SP-B fuses the bilayer with the air/water interface and (3) a DPPC enriched domain is subsequently inserted into
the interface.
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plus 12% would be required (plus selective non-
DPPC desorption). Yet the authors observed that
only a 30% reduction was required. Since the surfac-
tant preparation only contained the surfactant pro-
teins B and C, these are likely involved in this pro-
cess. Reconstitution of SP-B and SP-C separately in
lipid mixtures indicated that SP-B had a higher ac-
tivity in this regard [3]. Interestingly, the rate of ad-
sorption seems to be directly correlated to low com-
pressibility of the surface ¢lms which re£ects the
enrichment in DPPC [86,95]. During a fast adsorp-
tion, sudden decreases in the surface tension, the so-
called adsorption clicks, are observed. This re£ects
the movement of large amounts of lipids into the
monolayer. The combination of adsorption clicks
and low compressibility of the resulting ¢lm suggests
that aggregates or domains highly enriched in DPPC
are adsorbed during these clicks. It is tempting to
speculate that one or more of the surfactant proteins
plays a role in the formation of DPPC-rich lipid
domains in tubular myelin or other lipid bilayer
structures in close proximity of the interface. These
DPPC rich domains are subsequently inserted or
moved into the interface (Fig. 2). The domain for-
mation or the existence of lipid microheterogeneities
under the in£uence of surfactant proteins has been
proposed before [15,106], but evidence is scarce and
nothing is known about the mechanism by which this
would occur.
Even though the adsorption clicks do not depend
on the abundance of SP-A in the samples, a role for
SP-A in the ‘selective DPPC adsorbing’ mechanism
still seems likely. In a CBS study using surfactant
extracts, smaller area reductions were needed to
reach a low surface tension when SP-A was added
to the subphase. It is known that SP-A preferentially
binds DPPC [107] and interacts with the boundaries
between condensed and £uid regions in DPPC mono-
layers (see also below) [108]. SP-A was shown to
aggregate DPPC molecules in DPPC/cholesterol mix-
tures in vitro [109]. Unpublished studies in our lab-
oratory also support the DPPC domain forming role
of SP-A. In these studies, it was observed that SP-A
can induce a so-called ripple phase in unilamellar
liposomes composed of POPG and DPPC (Fig. 3).
This ripple phase, or PL phase, has ¢rst been de-
scribed by Tardieu et al. [110]. Contrary to ‘normal’
£uid phases (LK) or gel phase (LL), the membrane
surface is wrinkled. A model to explain this phenom-
ena has been proposed [111] in which the ripples are
considered to be alternating liquid phase and gel
phase regions, which in our experiments would prob-
ably represent POPG rich and DPPC rich domains,
respectively. Comparable experiments with DPPC/
eggPC mixtures were recently conducted as well by
Palaniyar et al. [112]. Interestingly, they observed a
corrugated membrane structure with this lipid mix-
ture even without the presence of SP-A. They also
suggest that this represents a phase separation be-
tween saturated and unsaturated phosphatidylcho-
lines. SP-A was in these experiments preferentially
localized in the ‘valleys’ of the corrugations which
would represent the DPPC enriched phase.
Some results are not in line with a role for the
hydrophobic proteins in the selective enrichment.
Comparison of spread and adsorbed surface ¢lms
on the Wilhelmy balance showed complete homology
under the epi£uorescent microscope [113,114]. The
number and size of the liquid condensed phases in
the monolayer as well as the localization of labeled
SP-C in the £uid phase were indistinguishable for
both methods of surface ¢lm formation. In CBS
Fig. 3. Cryo-TM image of an SP-A induced ripple phase. Large
unilamellar vesicles of DPPC:POPG in Tris/NaCl bu¡er were
incubated with SP-A. After 5 min, a ripple phase is observed in
the vesicles.
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studies, subtle di¡erences were observed between
spread and absorbed ¢lms. The compressibility was
higher for adsorbed ¢lms, actually indicating a selec-
tive diminishing of DPPC adsorption [87]. Maximum
and minimum surface tensions during cycling were at
some stages higher for the spread ¢lms. However, the
authors concluded that the di¡erences did not re£ect
‘true’ di¡erences between the ¢lms, but di¡erences
caused by the experimental approach.
(2) Evidence for the selective removal of non-
DPPC compounds during surface ¢lm compression
has been obtained from studies utilizing the Wil-
helmy balance, the PBS and the CBS. SP-B and
SP-C both seem to be involved in the selective re-
moval of non-DPPC compounds, despite some con-
trasting results. Both proteins localize in the £uid
phases of lipid monolayers [88,115] (see below). Us-
ing surface pressure^area isotherms in Wilhelmy bal-
ance studies it was observed that SP-B is partially
squeezed out at a surface pressure of 40 mN/m (sur-
face tension of 30 mN/m at 37‡C) while SP-C is
partially squeezed out at 55 mN/m (tension of
15 mN/m). SP-C is accompanied by 7^10 lipid mol-
ecules during the removal from the monolayer, con-
trary to SP-B which does not, or at least to a much
lower extent, show this e¡ect [116,117]. No speci¢city
of SP-C for accompanying lipids has been proven
[116,118], but combined with the above-mentioned
localization in the £uid phase of the monolayer con-
taining non-DPPC lipids [119] it seems reasonable to
suggest that this is a non-DPPC lipid removing
mechanism (Fig. 4). Supporting this hypothesis is
the e¡ect of SP-C incorporation on the minimum
surface tension of spread ¢lms in CBS studies.
Even though a lipid sample without SP-C also
reached very low minimum surface tensions during
cycling, the values obtained when SP-C was present
were signi¢cantly lower [73]. The same e¡ect is seen
Fig. 4. Hypothetical in vitro model for selective squeeze out of non-DPPC lipids. (1) SP-C is present in the lipid monolayer at the air/
liquid interface, as is the case in CBS or Wilhelmy balance studies. (2) The interface area is decreased (expiration) and £uid and gel
phases are formed. SP-C localizes in the £uid phase containing non-DPPC lipids. (3) Overcompression of the interface, the monolayer
deforms and lipids are squeezed out. (4) SP-C is also squeezed out, leaving the acyl chains in the monolayer, bridging the squeezed
out lipids to the interface.
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when adsorbed ¢lms of SP-C/lipid mixtures are used
[78]. However, in PBS studies, a smaller e¡ect of SP-
C in this respect was observed. Adsorbed DPPC/PG/
SP-C ¢lms failed to reach low surface tensions even
after extensive cycling. Contrary to this, a clear re-
¢nement of the monolayer during cycling was ob-
served for SP-B mixtures indicative of selective
non-DPPC squeeze out [97]. Interestingly, a recent
report by Nag et al. describes that this e¡ect of SP-
B is speci¢c for acidic lipids. A clear re¢nement of
the surface ¢lm was observed for DPPC/PG/SP-B
mixtures, but not with mixtures in which POPG
was replaced by POPC [120].
3.2.3. Surface ¢lm reservoir formation
It is now generally accepted that the surface ¢lm at
the interface does not consist solely of a monolayer
of lipids, but of a complex membrane system com-
posed of a monolayer with bilayer structures at-
tached to it. Recently, the occurrence of the de-
scribed structures in vivo was reported. Electron
micrographs of the alveolar lining layer in rabbit
lung showed sites with multilayers of lipids at the
interface [2,3].
In model systems, indications for such structures
have been observed. Wilhelmy balance studies have
shown clearly that lipids that are squeezed out dur-
ing overcompression of the monolayer, stay in close
proximity to the interface [59]. During the next ex-
pansion, these lipids can re-insert. This dynamic cy-
cling can be performed without signi¢cant loss of
material when SP-C and especially SP-B were
present.
Oosterlaken-Dijksterhuis et al. reported in 1991
that SP-B and SP-C promote insertion of lipids
from vesicles associated with a preformed spread
phospholipid monolayer [80]. These associated
vesicles could not be washed away with extensive
£ushing of the subphase, even in the absence of cal-
cium ions, indicating that they were ¢rmly attached
to the spread monolayer. These results also suggests
that the reservoir does not solely consist of squeezed
out lipids, but can at least partly be formed by at-
tachment of subphase lipids. Similar results were ob-
tained with spread surface ¢lms in the CBS where the
protein/lipid reservoir stayed attached to the inter-
face during dynamic cycling [121]. A tightly bound
reservoir was also observed in CBS experiments
when SP-C/lipid samples [78] or surfactant lipid ex-
tracts [2] were used. In these experiments, a ¢lm is
absorbed after which the subphase is replaced by a
salt solution without disturbing the bubble. Upon the
next expansion the lipids in the reservoir can be re-
inserted into the interface, lowering the surface ten-
sion. This e¡ect was dependent on the palmitoyl
chains of SP-C. This interesting ¢nding may indicate
a role of the acyl chains of SP-C in bridging the
monolayer to the lipid bilayers underneath. SP-B
had, contrary to the Wilhelmy balance studies,
some reservoir-forming e¡ect, but to a much lower
extent than SP-C. Interestingly, SP-B1ÿ25, a peptide
that represents the ¢rst 25 amino acids of SP-B,
mimics many of the protein’s activity, but not the
surface reservoir formation. However, this activity
could be introduced by synthetic dimerization of
this peptide [127]. This suggests that the dimerized
form of natural SP-B does play a role in the reservoir
formation.
Recently new reports describing the formation of
these reservoirs associated with the monolayer have
been published [88]. Scanning force microscopy of
collapsed SP-C containing surface ¢lms showed
Fig. 5. Pseudo-three-dimensional view of squeezed out phospho-
lipid bilayer stacks. Upon compression of a monolayer of lipids
and SP-C, lipids are squeezed out but stay attached to the
monolayer, forming the observed protrusions. Each single step
is about 6 nm high. The picture is 1.2U1 Wm. Permission for
reprint of this ¢gure was kindly granted by Dr. Matthias Am-
rein and the Biophysical Society.
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that phospholipid bilayers were stacked in the SP-C
rich regions and piles of up to four bilayers were
found (Fig. 5). These stacks were not found in col-
lapsed protein-free lipid ¢lms. Upon expansion of the
surface area, these lipid stacks were inserted into the
monolayer again. Similar results were obtained using
£uorescently labeled SP-C in monolayers [122]. Upon
reduction of the surface area, the £uorescence was
quenched, indicative of increasing concentrations of
SP-C in small domains. Further compression led to a
constant surface pressure accompanied by an in-
crease in £uorescence which is, according to the au-
thors, representing the formation of multilayer stacks
under the monolayer. It will be very interesting to see
whether similar experiments with SP-B and especially
non-acylated SP-C will also be in line with the results
obtained by the CBS experiments.
3.2.4. Modulation of monolayer packing
The use of £uorescently labeled surfactant proteins
and £uorescent lipid analogues has greatly enhance
insight into the behavior of especially the hydropho-
bic surfactant proteins in the surface ¢lm. SP-B and
SP-C seem to have the same e¡ect on monolayers,
observed by epi£uorescent microscopy, which is that
they create more, but smaller, gel-like condensed
phases [115]. Both proteins localize in the £uid phase
regions of the monolayers [115] and are squeezed out
at increasing surface pressure (40 mN/m for SP-B
and 55 mN/m for SP-C). Small amounts of the pro-
teins stay within the monolayer, also at pressures of
65 mN/m. Re-insertion of the proteins is observed
during re-expansion of the interface surface. If both
proteins are present in a pure DPPG monolayer, but
not in a DPPC:DPPG mixture, both are simultane-
ously squeezed out at 55 mN/m [123]. This phenom-
enon is calcium dependent and might indicate an
association of both proteins. In pure palmitic acid
monolayers SP-B and also SP-B1ÿ25 induced a ¢ne
‘£uid’ network around condensed domains at high
surface pressures [124]. The authors conclude that
the observed structural arrangement might actually
be the main reason for the stability and £exibility of
the surfactant ¢lm. However, the results of this study
should be interpreted cautiously because of the
monolayer composition and the high amounts of
peptides used.
4. Summarizing conclusions and future directions
The knowledge regarding the formation and dy-
namics of the surface ¢lm at the air/liquid interface
has increased signi¢cantly over the last decades.
Starting with a simple DPPC monolayer model, it
is now widely accepted that a surface ¢lm consisting
of a monolayer in close contact with multilayers is
the active structure at the interface. Several dynamic
processes occur in the ¢lm during breathing includ-
ing, amongst others, selective adsorption of DDPC
enriched domains, speci¢c squeeze-out of non-DPPC
lipids, lipid reservoir formation and modulation of
monolayer packing. Each process probably requires
the combined action of both lipid and protein com-
ponents of surfactant. In vivo experiments have re-
vealed some structural information, but most de-
tailed knowledge about this complex issue has to
be gained by in vitro experiments using model sys-
tems.
By far the most research in this area concentrates
on the role of SP-B and SP-C. Despite some appar-
ently contradicting results, some clear di¡erences re-
garding their surface active roles are now emerging
between these two hydrophobic surfactant proteins.
Especially the experiments utilizing the captive bub-
ble surfactometer, in which several aspects of the
surface ¢lm dynamics can be studied independently,
have proven to be very useful in this respect. SP-B
appears to be more e¡ective in adsorption while SP-
C plays a marked role in the lipid reservoir forma-
tion. However, it still remains remarkable, that two
such structurally di¡erent proteins seem to possess so
many overlapping activities. Since real proof of the
interaction of SP-B and SP-C with the lipids in the
surface ¢lm is lacking, one can only hypothesize
about the molecular mechanism by which SP-B and
SP-C ful¢ll their proposed roles. It will be a future
challenge to come up with evidence of, for example,
the lipid membrane bridging capabilities of both pro-
teins. Also, the exact localization from which the
hydrophobic proteins exert their function, monolayer
or underlying bilayer or both, is an interesting issue
that has to be clari¢ed.
The role of the minor lipid components of surfac-
tant is still far from clear. The high amounts of PG
and DPPC and, to a lower extent, cholesterol seem
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to distract the attention from the minor lipid com-
ponents. However, abundance does not necessarily
equal importance. Roles for the minor lipids in struc-
tural features of the surfactant ¢lm are bound to be
discovered with the sensitive techniques that are
available nowadays.
As with all in vitro experiments, one has to be very
careful with the interpretation of the obtained re-
sults. Artefacts that arise due to the speci¢c method-
ology are very common. The ‘golden rule’ to have
only one variable per experiment combined with the
complexity of the surfactant system will make it hard
to determine the cooperation between the surfactant
components. The determination of the activity of
each component separately in a certain aspect does
not lead to a complete picture by simply adding up
the results. Knock-out mice can provide a useful tool
to connect in vitro results with in vivo function. The
SP-A knock-out mouse is in this respect a good ex-
ample since many of the in vitro determined func-
tions could be tested. SP-B and more recently SP-C
knock-outs have been produced as well. As expected,
the SP-B knock-out mice only survive a few hours
after birth due to respiratory failure. Surprisingly,
the lack of SP-C in the recently generated SP-C
knock-out mice seems to have no in£uence on sur-
factant function and homeostasis [125]. These mice
seem to possess no respiratory failure and no
changes in surfactant pool sizes, phospholipid com-
position or oxygenation.
Despite some di⁄culties and the cautiousness that
has to be taken in interpreting the results, the genetic
techniques will de¢nitely provide further insight into
surface ¢lm behavior. Expression of SP-B mutant
forms in a SP-B knock-out background has for ex-
ample already been performed [126] and the behavior
of the SP-C knock-out mice under stress situations
will provide more detailed information on the func-
tion of the surfactant proteins. The variety of model
systems that are now available and the in vivo stud-
ies will prove to be a very strong combination to
clarify the molecular mechanism by which surface
¢lm homeostasis occurs.
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